Lyra Therapeutics (LYRA) Q2 2024 Earnings

30AprConfirmed
Q4 2022
Q2 2023
Q3 2023
Q2 2024
-0.42
-0.37
-0.31
-0.26

Details

Expected EPS
-0.262117
Actual EPS
-0.35
Surprise EPS
-0.09
Surprise Percent
+33.53%

Description

Lyra Therapeutics (LYRA) has reported earnings of -0.35 per share for Q2 2024.

0 Comments

Share your thoughts